Semaglutide works by slowing gastric emptying and activating GLP-1 receptors in the brain that regulate hunger and reward signals, which fundamentally shifts how you experience food satisfaction
Retatrutide (5mg-10mg), Triple Incretin Receptor Agonist Engineered Engagement of GLP-1, GIP, and Glucagon Receptors Introduction Engineered Engagement of GLP-1, GIP, and Glucagon Receptors Retatrutide is a synthetic 39-residue peptide engineered as a balanced agonist of three distinct class B G protein-coupled receptors: the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR)
Use caution if you have a history of melanoma, atypical moles, or other skin cancers, or if you take medicines that affect pigmentation or immune function
Fujimoto K, Nagafuchi A, Tsukita S, Kuraoka A, Ohokuma A, Shibata Y